HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

BCG for upper-tract transitional-cell carcinoma: is it safe in patients with renal compromise?

Abstract
We report three cases of end-stage renal failure necessitating hemodialysis subsequent to BCG administration for the treatment of upper-urinary tract transitional-cell carcinoma in patients with a solitary kidney, one with normal renal function and two with chronic renal failure prior to BCG instillation. We discuss treatment-related issues with pertinent literature review.
AuthorsSaleh Binsaleh, Kanishka Sircar, Mostafa Elhilali, Maurice Anidjar
JournalJournal of endourology (J Endourol) Vol. 20 Issue 12 Pg. 1068-71 (Dec 2006) ISSN: 0892-7790 [Print] United States
PMID17206904 (Publication Type: Case Reports, Journal Article)
Chemical References
  • BCG Vaccine
Topics
  • Aged
  • Aged, 80 and over
  • BCG Vaccine (therapeutic use)
  • Carcinoma, Transitional Cell (drug therapy, pathology)
  • Female
  • Humans
  • Male
  • Urologic Neoplasms (drug therapy, pathology, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: